The increasing demand for specific immunological investigation and therapeutic development has spurred significant improvements in recombinant signal molecule generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique biological roles, are frequently produced using various expression platforms, including prokaryotic hosts, mammalian cell line